Cystagon Capsule
Product Images NDC 0378-9045

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cystagon (NDC 0378-9045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cysteamine Bitartrate Structural Formula (3aab3b39 52b6 4a79 9a5c 7baa7574f24f 01)

FDA Label Image

The Mean White Cell Cystine Concentration And Mean Cysteamine Plasma Concentration-time Profile (3aab3b39 52b6 4a79 9a5c 7baa7574f24f 02)

FDA Label Image

Image 01

Each capsule contains 50 mg of cysteamine bitartrate and is stored at a temperature of 20° to 25°C in a tight, light-resistant container. Capsules have a child-resistant closure and are defined in the USP. Protect from light and moisture. This product has a code number MHDRUGS/25/NKD/D and is made in India. It comes in a pack of 500 capsules and has a GTIN 000000000000. The NDC code is 0378-9040-05, and the lot number is X000. For prescribing information, see the accompanying CYS TAGON®.*

FDA Label Image

Image 02

Each capsule of CYSTAGON contains 150mg of cysteamine bitartrate. It is important to keep this medication out of the reach of children, protected from light and moisture, and in a tight, light-resistant container with a child-resistant closure. A prescribing information leaflet should be dispensed with each prescription. The manufacturing company is Mylan Pharmaceuticals, located in Morgantown, WV, USA, with the capsules made in India. This medication is available only with the prescription of a physician.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.